About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials in Phoenix | 35 Studies

Clinical Trials PsoriasisPhoenix

Psoriasis Clinical Trials in Phoenix

Find 35 clinical trials for psoriasis near Phoenix, Arizona. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-35 of 35 trials

Active not recruitingA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPsoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).NCT06671496·Mesa, Arizona and 119 others

Psoriasis Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisThis is a study to compare the efficacy of bimekizumab versus placebo and an active comparator in the treatment of subjects with moderate to severe chronic plaque psoriasis (PSO).NCT03370133·Phoenix, Arizona and 104 others

TerminatedVTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)The objective of this study is to evaluate if VTX958 is safe and effective in adult participants with active Psoriatic Arthritis.NCT05715125·Phoenix, Arizona and 45 others

Enrolling by invitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic ArthritisThis is a study to demonstrate the long-term safety, tolerability and clinical efficacy of sonelokimab in the treatment of patients with psoriatic arthritis who completed a…NCT07223138·Avondale, Arizona and 16 others

CompletedStudy to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject EtanerceptThe purpose of this study is to assess the ability of people with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) to use an experimental autoinjector to self inject…NCT01901185·Huntsville, Alabama and 12 others

CompletedA Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisThis is a study to assess the long-term safety, long-term efficacy and tolerability of bimekizumab administered subcutaneously (sc) in adult subjects with psoriatic arthritis…NCT04009499·Phoenix, Arizona and 137 others

CompletedA Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic ArthritisThe purpose of the study is to compare the efficacy of bimekizumab versus risankizumab after 16 weeks of treatment in study participants with active psoriatic arthritis (PsA).NCT06624228·Gilbert, Arizona and 126 others

Active not recruitingA Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) TherapyThe purpose of this study is to compare the safety and efficacy of risankizumab versus placebo in participants with moderately to severely active psoriatic arthritis (PsA).NCT03675308·Anniston, Alabama and 255 others

CompletedA Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisThe main purpose of this study is to evaluate the safety and long-term efficacy of ixekizumab compared to placebo in participants with active psoriatic arthritis.NCT02584855·Glendale, Arizona and 105 others

Active not recruitingEvaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugThis is a study to demonstrate the clinical efficacy and safety of sonelokimab administered subcutaneously compared with placebo in the treatment of adult patients with active…NCT06641076·Avondale, Arizona and 181 others

CompletedA Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisThis is a study to demonstrate the clinical efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared with placebo in the treatment of tumor…NCT03896581·Phoenix, Arizona and 91 others

CompletedEfficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis who have not been previously treated with…NCT01307423·Phoenix, Arizona and 117 others

CompletedPALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisThe purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis and a qualifying psoriasis lesion.NCT01212770·Birmingham, Alabama and 90 others

CompletedCOVID-19 VaccinE Response in Rheumatology PatientsThe COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a multicenter randomized controlled trial designed to evaluate the efficacy and safety of a mRNA COVID-19…NCT05080218·Birmingham, Alabama and 7 others

CompletedA Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic DrugThis is a Phase 3 multicenter study that included two periods.NCT03104374·Mobile, Alabama and 164 others

PreviousPage 2 of 2

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia